Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure is a research paper published in JACC CardioOncology (2020). On theSindex it has a DataRank of 0.464. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Heart Association
Grant: 18SFRN3390085
National Institute on Aging
Grant: 1R03AG067960-01
Evaluation of Racial Differences in Cardiorespiratory Fitness Decline with Aging & Underlying Biological Mechanisms
NIA NIH HHS
Grant: R03 AG067960
National Institutes of Health
Grant: 5UL1TR002541-04
The Harvard Clinical and Translational Science Center
National Institutes of Health
Grant: 2T32HL007604-06
TRAINING PROGRAM IN CARDIOVASCULAR RESEARCH
Bayer Fund
Boehringer Ingelheim
Medicines Company
Merck
St. Jude Medical
American College of Cardiology Foundation
Duke Clinical Research Institute
National Heart, Lung, and Blood Institute
Regado Biosciences
AstraZeneca
CSL Behring
Mayo Clinic
Belvoir Media Group
Novo Nordisk
Abbott Laboratories
Icahn School of Medicine at Mount Sinai
Bristol-Myers Squibb
Gilead Sciences
National Center for Advancing Translational Sciences
Ferring Pharmaceuticals
National Institutes of Health
Cleveland Clinic
Takeda Pharmaceuticals U.S.A.
FWCI
0.68
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals